CALI CalciMedica Inc Year-over-year net earnings per share growth for the last 12 months

calcimedica.com - graphic logo of issuer CALI

CalciMedica, Inc. (CALI) is developing a system of CRAC inhibitors to combat inflammation through its drug Auxora. Quarterly earnings per share growth reflects the dynamics of this process, where the value of 0.00 corresponds to the current metric. Meanwhile, CalciMedica, Inc. (CALI) adheres to ESG standards by minimizing environmental impact. However, the lack of revenue and risks associated with clinical trials are exerting significant pressure on balance sheet liquidity.

calcimedica.com (CALI) Year-over-year earnings per share growth for the last 12 months: for the period 10/11/2024 - 10/17/2026

Analytical breakdowns and data insights for company calcimedica.com (CALI)

- market value and analyst target forecast:
- market capitalization data:
Initial company analysis:CalciMedica, Inc.
Flagship merchandise of CalciMedica, Inc.

This indicator reflects the dynamics of earnings per share, measuring the efficiency of capitalizing operating results through the lens of equity ownership to identify the asset's real undervaluation. For CalciMedica, Inc. (CALI), whose resilience is based on the protection of innovative molecules in inflammation therapy, the amplitude of quarterly EPS fluctuations serves as an indicator of patent commercialization and the predictability of the company's cash flows.

Direct competitors

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RAPT|JBIO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences, Ltd.)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc (CABA)|ventyxbio.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months theratech.com|AVTX: Quarterly EPS earnings growth|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus, Inc) - Quarterly EPS earnings growth|Climb Bio, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|ATYR - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adagene ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Year-over-year earnings per share growth for the last twelve months|Immunic, Inc. (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ATRA|IFRX: Year-over-year earnings per one share growth for the last 12 months|X4 Pharmaceuticals Inc. (XFOR) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Adicet ACET|Quarterly EPS earnings growth CELU (Celularity Inc)|Quarterly EPS earnings growth INmune Bio INMB|Barinthus Biotherapeutics plc - Quarterly EPS earnings growth|Kezar Life Sciences, Inc. (KZR) - Year-over-year net earnings per share growth for the last 12 months|SAB Biotherapeutics, Inc (SABS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Akari Therapeutics plc|Year-over-year earnings per share growth for the last twelve months enlivex.com|Earnings per share growth in annualized terms for the last twelve months q32bio.com QTTB|Year-over-year earnings per share growth for the last twelve months GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ibioinc.com IBIO|Quarterly EPS earnings growth carismatx.com CARM|XTLB - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Aptevo|Year-over-year net earnings per share growth for the last 12 months AIM|Year-over-year earnings per share growth for the last 12 months ADTX (aditxt.com)|Year-over-year earnings per share growth for the last twelve months GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HIND (Vyome Therapeutics)|REVB - Year-over-year net earnings per share growth for the last 12 months|INDP: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCNI (Scinai)|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months